Rankings · Price against the business

Most free cash flow per dollar of price

Graded A or B, ranked by free cash flow over the last twelve months divided by market value. Banks and insurers are left out, and yields above 50% are treated as data problems rather than bargains.

125 companies meet this test

Figures as of November 15, 2026

#CompanyGradeFree cash flow yieldP/ERevenue growthMarket value
1GMABGenmab A/SB+35.7%3.34+18% a year$3.2B
2NRIXNURIX THERAPEUTICS, INC.A+21.9%6.73—$1.7B
3BCRXBIOCRYST PHARMACEUTICALS, INC.B18.7%—+45% a year$2B
4HRMYHARMONY BIOSCIENCES HOLDINGS, INC.B+17.5%11.14+22% a year$2B
5TAKTakeda Pharmaceutical Company LimitedA16.0%50.12+3% a year$34.4B
6GRFSGrifols SAA14.8%33.82+7% a year$5.9B
7THCTENET HEALTHCARE CORPA+14.6%8.30+3% a year$22.8B
8SNYSanofiB13.7%6.80+4% a year$59B
9ANIPANI PHARMACEUTICALS, INCB+13.3%14.26+32% a year$1.5B
10PCRXPACIRA BIOSCIENCES, INC.B11.6%39.20+4% a year$1.5B
11ARDTArdent Health, Inc.B11.3%17.28+6% a year$2.5B
12AMPHAmphastar Pharmaceuticals, Inc.B+11.1%13.41+7% a year$1.3B
13JAZZJazz Pharmaceuticals plcA10.5%78.68+8% a year$15.5B
14UHSUNIVERSAL HEALTH SERVICES, INC.B9.7%8.13+9% a year$11.5B
15ZBHZIMMER BIOMET HOLDINGS, INC.B8.4%26.06+6% a year$19.5B
16VCYTVERACYTE, INC.A+8.2%15.80+19% a year$2B
17GMEDGLOBUS MEDICAL, INC.B+7.9%17.77+37% a year$9.7B
18GSKGSK plcA+7.9%13.56+4% a year$108.9B
19HALOHALOZYME THERAPEUTICS, INC.A+7.7%25.01+32% a year$11.4B
20IARTINTEGRA LIFESCIENCES HOLDINGS CORPB7.7%84.71+2% a year$1.1B
21HLNHaleon plcB+7.5%18.50+1% a year$41B
22CAHCardinal Health, Inc.B7.0%38.88+7% a year$65B
23EXELEXELIXIS, INC.A+6.9%20.66+12% a year$16.8B
24GILDGILEAD SCIENCES, INC.A6.6%—+4% a year$208.5B
25ADUSAddus HomeCare CorpB6.3%20.47+13% a year$2.3B

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.